BOL-DP-o-05 / BOL Pharma - LARVOL DELTA

BOL-DP-o-05 as an Add-On Treatment of Subjects With Newly Diagnosed Type 1 Diabetes Mellitus (clinicaltrials.gov) - P2a; N=0; Withdrawn; Sponsor: Breath of Life International Pharma Ltd; N=60 ➔ 0; Trial completion date: Nov 2021 ➔ Mar 2021; Not yet recruiting ➔ Withdrawn; Trial primary completion date: Nov 2021 ➔ Mar 2021

Clinical • Enrollment change • Trial completion date • Trial primary completion date • Trial withdrawal • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus